NanoCellect Biomedical
NanoCellect Biomedical is a private San Diego biotech that develops microfluidic cell sorting instruments and consumables. Its WOLF G2 and VERLO platforms use low-pressure piezoelectric technology to gently sort fragile cells for pharmaceutical, biotech, and academic research customers.
- Company typePrivate
- Founded2011
- HeadquartersSan Diego, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What NanoCellect Biomedical does
NanoCellect Biomedical is a privately held life sciences instrumentation company headquartered in San Diego, California, that develops and commercializes microfluidic cell sorting platforms and consumables for biomedical research. The company's core technology uses low-pressure (<2 psi) piezoelectric actuation in disposable cartridges to gently sort cells — a deliberate contrast to traditional droplet-based electrostatic cell sorters that operate at higher pressures and can damage fragile cell types such as stem cells, induced pluripotent stem cells (iPSCs), primary neurons, and plant protoplasts.
The product portfolio centers on the WOLF G2 Cell Sorter (launched 2021), a benchtop dual-laser instrument supporting up to nine fluorescent colors, and the VERLO Image-Guided Cell Sorter (launched 2024), which combines flow cytometry with real-time image-based sorting across 12 imaging channels. Supporting offerings include the N1 Single-Cell Dispenser, CS1 Chiller-Stirrer, and CX2 Collection Cooler accessories, recurring consumables (disposable microfluidic cartridges and calibration beads), and tiered service contracts (Basic, Standard, Premium) plus Installation and Operational Qualification (IQ/OQ) services. Revenue is generated through a hybrid go-to-market: direct enterprise field sales for capital equipment, a global distributor network for international coverage, and an e-commerce shop for consumables. Customers include pharmaceutical and biotech firms (Takeda, Calico Life Sciences, contract development and manufacturing organizations), academic and medical research institutions (Mount Sinai, Rice University, Case Western Reserve University, UC Irvine, University of Michigan, Children's Hospital of Philadelphia), and cell therapy startups (Pluristyx), with applications spanning antibody discovery, cell line development, single-cell genomics, gene editing/CRISPR workflows, and stem cell research. The company has raised approximately $35M+ across disclosed rounds, most notably a $20M Series D led by Warburg Pincus in 2021 and a follow-on investment from Paladin Capital Group in 2023.
NanoCellect Biomedical firmographics
Firmographics- Name
- NanoCellect Biomedical
- Legal name
- NanoCellect Biomedical, Inc.
- Website
- https://nanocellect.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- NanoCellect Biomedical is a private San Diego biotech that develops microfluidic cell sorting instruments and consumables. Its WOLF G2 and VERLO platforms use low-pressure piezoelectric technology to gently sort fragile cells for pharmaceutical, biotech, and academic research customers.
- Ownership category
- akta.pro rank
NanoCellect Biomedical industry classification
Industry- Product category
- Cell Sorting Instruments
- NAICS
- Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
Keywords
Where NanoCellect Biomedical is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
NanoCellect Biomedical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Revenue model
- Instrument Sales: Sale of WOLF G2 and VERLO cell sorter instruments along with accessories (N1 Single-Cell Dispenser, CS1 Chiller-Stirrer, CX2 Collection Cooler) as capital equipment purchases.
- Consumables: Recurring revenue from disposable microfluidic cartridges (bulk and single-cell sorting) and calibration beads sold through web shop and quotes.
- Service Contracts: Annual service contracts (Basic, Standard, Premium) covering instrument maintenance, preventive maintenance, priority support, training, and depot repair services.
- Qualification Services: Installation Qualification (IQ) and Operational Qualification (OQ) services for regulatory compliance verification of WOLF G2 systems and accessories.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | WOLF G2 Cell Sorter - Quote-based pricing |
| One time/ perpetual license | Pay-as-you-go | VERLO Image-Guided Cell Sorter - Quote-based pricing |
| Unit Pricing | Pay-as-you-go | Microfluidic Cartridges - Pack pricing |
| Subscription | Annual | Service Contracts - Three tiers |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
NanoCellect Biomedical product offering
Product offeringCore offering
NanoCellect develops, manufactures, and commercializes microfluidic cell sorting instruments (WOLF G2 and VERLO Image-Guided Cell Sorter) that use low-pressure (<2 psi) piezoelectric actuation in disposable cartridges for gentle, contamination-free cell sorting. The company sells the instruments, supporting accessories (N1 Single-Cell Dispenser, CS1 Chiller-Stirrer, CX2 Collection Cooler), consumables (microfluidic cartridges and calibration beads), and service contracts to academic, pharmaceutical, and biotech research customers.
Product overview
NanoCellect Biomedical offers a family of microfluidic cell sorting instruments centered on gentle, low-pressure sorting technology. The core product portfolio consists of the WOLF G2 Cell Sorter (entry-level microfluidic benchtop sorter with dual lasers and up to nine colors) and the VERLO Image-Guided Cell Sorter (advanced imaging flow cytometry platform combining label-free and fluorescent detection with image-based cell sorting). Key accessories include the N1 Single-Cell Dispenser for plate-based single-cell deposition, the CS1 Chiller-Stirrer for temperature-sensitive samples, and the CX2 Collection Cooler for post-sort sample preservation. Supporting consumables include microfluidic cartridges (bulk and single-cell configurations) and calibration beads. Service offerings encompass Basic, Standard, and Premium service contracts with preventative maintenance options, plus Installation and Operational Qualification (IQ/OQ) services. Educational resources include Lunch & Learn sessions.
Differentiator
Problem solved
Functional benefit
Brands
- WOLF G2: Benchtop microfluidic cell sorter with two lasers and up to nine colors for gentle cell sorting in research applications.
- VERLO
- N1 Single-Cell Dispenser
- CS1 Chiller-Stirrer
- CX2 Collection Cooler
- WOLFViewer
- WOLF Spectra Viewer
Products and services
- VERLO Image-Guided Cell Sorter World's first two-laser image-guided cell sorter combining conventional flow cytometry with imaging technology. Features 9 fluorescent channels, 3 label-free channels, and 12 imaging channels total, enabling visualization, analysis and sorting based on cell morphology, subcellular localization, and cell-cell interactions. Targeted at biomedical researchers needing morphology-based sorting.
- WOLF G2 Cell Sorter Benchtop microfluidic cell sorter featuring dual lasers and up to nine fluorescent colors. Operates at less than 2 psi for gentle cell sorting, preserving cell viability and integrity. Supports both bulk sorting and single-cell dispensing into 96- or 384-well plates via the N1 accessory. Targeted at academic, pharmaceutical, and biotech researchers.
- N1 Single-Cell Dispenser Accessory module for WOLF cell sorters enabling single-cell deposition into 96- or 384-well plates. Provides higher rates of singlet detection compared to cell printers or limiting dilution methods, with deposition volumes of 3-10 µL per well.
- CS1 Chiller-Stirrer
- CX2 Collection Cooler
- Microfluidic Cartridges
- Calibration Beads
- Service Contracts (Basic, Standard, Premium)
- Installation and Operational Qualification (IQ/OQ)
Quantifiable outcome
- Up to 93% single-cell plating efficiency for iPSCs compared to lower efficiency with non-sorting methods
- +6 more outcomes
Companies that use NanoCellect Biomedical
Customer profileNamed customers10 records
Segments5 records
Ideal customer profiles4 records
NanoCellect Biomedical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature6 records
NanoCellect Biomedical partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Professor Yuhwa Lo, PhD (UC San Diego)coreCo-founder and Chairman of NanoCellect's Scientific Advisory Board. Near 20 years of collaboration with Professor Lo has been awarded over $13 million in NIH SBIR Awards. His research expertise in microfluidics and biomedical engineering has been foundational to the company's technology development.
Scale indicators3 records
Recent moves5 records
Expansion highlights6 records
NanoCellect Biomedical competitors and assessment
Company assessmentDirect peers
- BD Biosciences: Becton Dickinson's life-sciences arm manufactures the FACSDiscover, FACSymphony, and FACSAria cell sorters and is the dominant incumbent in flow cytometry. BD directly competes with NanoCellect in cell sorting and is now extending into image-enabled sorting (BD CellView), making it the most direct peer.
- Beckman Coulter Life Sciences: A Danaher operating company shipping the MoFlo Astrios, CytoFLEX S, and Navios flow cytometers/sorters. Competes head-to-head with NanoCellect across academic and pharma research labs, particularly in cell line development and immunology workflows.
- Sony Biotechnology: Sony's life-sciences subsidiary markets the SH800, MA900, and CGX10 cell sorters targeting single-cell sorting workflows. Directly comparable to the WOLF G2 in benchtop form factor and use cases such as stem cell and antibody discovery sorting.
- Cytek Biosciences: Cytek offers the Aurora and Northern Lights spectral flow cytometers and the Cytek Aurora CS cell sorter, widely adopted in academic and pharma immunology and cell therapy labs. A direct peer in the gentle, high-content flow cytometry space NanoCellect targets.
- Standard BioTools: Formerly Fluidigm, Standard BioTools markets the Hyperion XTi imaging mass cytometer and the CyTOF XT — both imaging-based single-cell platforms. Comparable to NanoCellect's VERLO strategy of combining imaging with high-content single-cell analysis.
Broad incumbents
- Thermo Fisher Scientific: Thermo Fisher sells the Invitrogen Attune NxT flow cytometer and a broad portfolio of cell analysis reagents and instruments. Overlaps with NanoCellect in cell sorting and flow cytometry but as part of a much larger life-sciences tools portfolio.
- Agilent Technologies: Agilent is a strategic investor in NanoCellect via Agilent Ventures and also operates the Seahorse and cell-analysis portfolio plus the recently acquired Resolution Bioscience/Olaris assets. A broad incumbent adjacent to NanoCellect in cell line development analytics.
Emerging players
- Applied Cells: Applied Cells' MARS (Magnetic-Reduced Shear) rare-cell sorting technology is a documented NanoCellect partner. Comparable as a smaller, emerging player in gentle/rare-cell isolation that intersects with NanoCellect's fragile-cell-sorting niche.
- Cytovale: Cytovale develops rapid cell-based diagnostic platforms (IntelliSep) using deformability cytometry. Adjacent to NanoCellect in applying novel cell-measurement modalities to clinical and research workflows.
Others
- 10x Genomics: 10x Genomics is a downstream single-cell genomics platform partner (Chromium, Visium) with which NanoCellect co-markets WOLF-based sample preparation. Not a direct competitor but a key ecosystem partner for NanoCellect's genomics customer segment.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
NanoCellect Biomedical social profiles
Digital presenceNanoCellect Biomedical financial estimates
Financial estimateRevenue estimate
Valuation estimate
NanoCellect Biomedical leadership team
Management profileNumber of profiles
Profiles6 records
NanoCellect Biomedical funding detail
Funding detailFunding overview
Funding rounds6 records
Investors14 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NanoCellect Biomedical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NanoCellect Biomedical
What does NanoCellect Biomedical do?
NanoCellect develops, manufactures, and commercializes microfluidic cell sorting instruments (WOLF G2 and VERLO Image-Guided Cell Sorter) that use low-pressure (<2 psi) piezoelectric actuation in disposable cartridges for gentle, contamination-free cell sorting. The company sells the instruments, supporting accessories (N1 Single-Cell Dispenser, CS1 Chiller-Stirrer, CX2 Collection Cooler), consumables (microfluidic cartridges and calibration beads), and service contracts to academic, pharmaceutical, and biotech research customers.
Is NanoCellect Biomedical a public or private company?
NanoCellect Biomedical is a private company. It is classified as venture growth investor backed and is currently operating.
When was NanoCellect Biomedical founded?
NanoCellect Biomedical was founded in 2011. It employs 51 to 100 people.
Where is NanoCellect Biomedical based?
NanoCellect Biomedical is headquartered in San Diego, United States, in the North America region.
How does NanoCellect Biomedical make money?
Four revenue lines are on record. Instrument Sales are the primary driver. The others are consumables, service Contracts and qualification Services.
Who are NanoCellect Biomedical's main competitors?
Direct peers on record are BD Biosciences, Beckman Coulter Life Sciences, Sony Biotechnology, Cytek Biosciences and Standard BioTools. Broad incumbents are Thermo Fisher Scientific and Agilent Technologies. Emerging players are Applied Cells and Cytovale. 10x Genomics is listed as an others.
Does NanoCellect Biomedical have an API?
No public API is recorded for NanoCellect Biomedical.
What industry is NanoCellect Biomedical in?
NanoCellect Biomedical's product category is Cell Sorting Instruments. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments. Its NAICS code is 3345 and its SIC code is 3826.